Acute kidney injury treatment sales will strengthen through 2036, anchored by dialysis at 55.6% share of the treatment type segment in 2025. Pre-renal injury represents 47.3% share of the injury type segment in 2025. The market is expected to reach USD 2.7 billion in 2026 and USD 5.6 billion by 2036.